1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The RSV therapeutics market is undergoing significant transformation as critical unmet needs and scientific advances drive industry innovation and strategic decision-making. Senior leaders are responding to mounting cost pressures, regulatory changes, and new partnerships to ensure effective and sustainable solutions reach global patient populations.
Market Snapshot: RSV Therapeutics Opportunities and Growth
Respiratory syncytial virus (RSV) continues as a major cause of severe lower respiratory tract infections worldwide, especially in infants, older adults, and those with compromised immune systems. The market has seen momentum in next-generation monoclonal antibodies, small molecule therapies, and advanced vaccine platforms. Regulatory agencies have fast-tracked evaluations for promising candidates, while strategic alliances among pharmaceutical and biotech companies are expanding access and accelerating R&D timelines. Companies are reassessing production and distribution strategies in light of new tariff environments and evolving healthcare delivery models.
Scope & Segmentation of the RSV Therapeutics Market
- Product Types: Monoclonal antibodies (nirsevimab, palivizumab), small molecule therapies (fusion inhibitors, polymerase inhibitors), vaccines (live attenuated, messenger RNA, recombinant)
- Routes of Administration: Intramuscular, intravenous, oral, subcutaneous
- Patient Types: Adult (younger, middle-aged, older), geriatric, pediatric (infant, neonate, toddler)
- End Users: Outpatient clinics, specialty clinics, home healthcare (caregiver and self-administration), hospitals (private and public)
- Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy
- Geographies: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and others), Asia-Pacific (China, India, Japan, Australia, and more)
- Key Companies: AstraZeneca PLC, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, Gilead Sciences, Inc., Moderna, Inc., Novavax, Inc.
Key Takeaways: Strategic Insights for Stakeholders
- Next-generation therapies such as monoclonal antibodies and small molecule antivirals address both breadth of coverage and improved safety, enhancing options for vulnerable patient groups.
- New vaccine technologies are enabling stronger, longer-lasting immunity and creating additional opportunities for market differentiation.
- Regulatory acceleration, including breakthrough and rolling review pathways, shortens the route to market for innovative candidates and fosters faster adoption.
- Integrated clinical trial models combining adaptive designs and real-world data are supporting more robust evaluations of RSV interventions.
- Collaborative frameworks among industry, academia, and contract organizations are de-risking development and broadening early access across diverse regions.
- Product strategies tailored to specific administration routes, patient segments, and clinical settings are driving both adoption and patient adherence.
2025 Tariff Impact: Cost Dynamics and Supply Chain Shifts
The 2025 United States tariff implementation introduces increased production costs for RSV therapeutics, particularly affecting those using imported active ingredients and specialized components. Companies must consider whether to absorb these expenses or adjust pricing, balancing profitability with market access. Supply chain strategies are evolving as organizations explore domestic manufacturing, nearshoring, and partnerships with contract manufacturers in lower-tariff areas. Strengthened collaborations between suppliers and distributors will play a pivotal role in maintaining supply chain resilience and cost control in a challenging trade environment.
Methodology & Data Sources
This report integrates thorough secondary research from peer-reviewed publications, regulatory filings, and company reports. In-depth interviews with domain experts and industry executives add practical insight into pipeline, trial innovation, and tariff impacts. Data triangulation and scenario modeling ensure conclusions reflect both rigorous data analysis and operational realities.
Why This Report Matters
- Delivers a comprehensive view of market segmentation, technology dynamics, and emerging business models in RSV therapeutics.
- Equips decision-makers with actionable insights into regulatory strategies, supply chain resilience, and partnership opportunities amid evolving cost pressures.
- Enables informed planning for product positioning, investment prioritization, and adaptation to technological and regional market shifts.
Conclusion
The RSV therapeutics landscape is defined by scientific advances, regulatory changes, and complex geographies. This report provides executives with the clarity and context needed to lead innovation and capture emerging opportunities efficiently and effectively.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in long-acting monoclonal antibodies for RSV prophylaxis in infants and elderly
5.2. Impact of novel small molecule fusion inhibitors on RSV treatment efficacy
5.3. Trends in pediatric RSV vaccine development leveraging mRNA platforms and adjuvants
5.4. The role of real-world evidence in supporting RSV therapeutic drug approvals and reimbursement
5.5. Competitive landscape analysis of emerging RSV combination therapies with antiviral and immunomodulator agents
5.6. Regulatory pathways and accelerated approval timelines for RSV therapeutics in major markets
5.7. Market access challenges for high-cost RSV prophylactic treatments in emerging economies
5.2. Impact of novel small molecule fusion inhibitors on RSV treatment efficacy
5.3. Trends in pediatric RSV vaccine development leveraging mRNA platforms and adjuvants
5.4. The role of real-world evidence in supporting RSV therapeutic drug approvals and reimbursement
5.5. Competitive landscape analysis of emerging RSV combination therapies with antiviral and immunomodulator agents
5.6. Regulatory pathways and accelerated approval timelines for RSV therapeutics in major markets
5.7. Market access challenges for high-cost RSV prophylactic treatments in emerging economies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Respiratory Syncytial Virus Therapeutic Drugs Market, by Product Type
8.1. Introduction
8.2. Monoclonal Antibody
8.2.1. Nirsevimab
8.2.2. Palivizumab
8.3. Small Molecule Therapy
8.3.1. Fusion Inhibitor
8.3.2. Polymerase Inhibitor
8.4. Vaccine
8.4.1. Live Attenuated Vaccine
8.4.2. Messenger Rna Vaccine
8.4.3. Recombinant Vaccine
8.2. Monoclonal Antibody
8.2.1. Nirsevimab
8.2.2. Palivizumab
8.3. Small Molecule Therapy
8.3.1. Fusion Inhibitor
8.3.2. Polymerase Inhibitor
8.4. Vaccine
8.4.1. Live Attenuated Vaccine
8.4.2. Messenger Rna Vaccine
8.4.3. Recombinant Vaccine
9. Respiratory Syncytial Virus Therapeutic Drugs Market, by Route Of Administration
9.1. Introduction
9.2. Intramuscular
9.3. Intravenous
9.4. Oral
9.5. Subcutaneous
9.2. Intramuscular
9.3. Intravenous
9.4. Oral
9.5. Subcutaneous
10. Respiratory Syncytial Virus Therapeutic Drugs Market, by Patient Type
10.1. Introduction
10.2. Adult
10.2.1. Middle Aged
10.2.2. Older Adult
10.2.3. Younger Adult
10.3. Geriatric
10.4. Pediatric
10.4.1. Infant
10.4.2. Neonate
10.4.3. Toddler
10.2. Adult
10.2.1. Middle Aged
10.2.2. Older Adult
10.2.3. Younger Adult
10.3. Geriatric
10.4. Pediatric
10.4.1. Infant
10.4.2. Neonate
10.4.3. Toddler
11. Respiratory Syncytial Virus Therapeutic Drugs Market, by End User
11.1. Introduction
11.2. Clinic
11.2.1. Outpatient Clinic
11.2.2. Specialty Clinic
11.3. Home Healthcare
11.3.1. Caregiver Administration
11.3.2. Self Administration
11.4. Hospital
11.4.1. Private Hospital
11.4.2. Public Hospital
11.2. Clinic
11.2.1. Outpatient Clinic
11.2.2. Specialty Clinic
11.3. Home Healthcare
11.3.1. Caregiver Administration
11.3.2. Self Administration
11.4. Hospital
11.4.1. Private Hospital
11.4.2. Public Hospital
12. Respiratory Syncytial Virus Therapeutic Drugs Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Americas Respiratory Syncytial Virus Therapeutic Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Respiratory Syncytial Virus Therapeutic Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Respiratory Syncytial Virus Therapeutic Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AstraZeneca PLC
16.3.2. Sanofi S.A.
16.3.3. AbbVie Inc.
16.3.4. GlaxoSmithKline plc
16.3.5. Pfizer Inc.
16.3.6. Merck & Co., Inc.
16.3.7. Johnson & Johnson
16.3.8. Gilead Sciences, Inc.
16.3.9. Moderna, Inc.
16.3.10. Novavax, Inc.
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AstraZeneca PLC
16.3.2. Sanofi S.A.
16.3.3. AbbVie Inc.
16.3.4. GlaxoSmithKline plc
16.3.5. Pfizer Inc.
16.3.6. Merck & Co., Inc.
16.3.7. Johnson & Johnson
16.3.8. Gilead Sciences, Inc.
16.3.9. Moderna, Inc.
16.3.10. Novavax, Inc.
List of Figures
FIGURE 1. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET: RESEARCHAI
FIGURE 26. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET: RESEARCHAI
FIGURE 26. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY NIRSEVIMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY NIRSEVIMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PALIVIZUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PALIVIZUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY FUSION INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY FUSION INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY POLYMERASE INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY POLYMERASE INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MESSENGER RNA VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MESSENGER RNA VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MIDDLE AGED, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MIDDLE AGED, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY OLDER ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY OLDER ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY YOUNGER ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY YOUNGER ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INFANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY NEONATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY NEONATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY TODDLER, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY TODDLER, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CAREGIVER ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CAREGIVER ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 161. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 164. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 165. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 166. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 167. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 168. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 169. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 174. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 175. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 176. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 177. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 180. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 181. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 182. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 183. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 184. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 185. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 190. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 191. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 192. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 193. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 200. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 201. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 202. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 203. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 206. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 207. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 210. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 211. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY NIRSEVIMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY NIRSEVIMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PALIVIZUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PALIVIZUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY FUSION INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY FUSION INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY POLYMERASE INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY POLYMERASE INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MESSENGER RNA VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MESSENGER RNA VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MIDDLE AGED, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MIDDLE AGED, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY OLDER ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY OLDER ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY YOUNGER ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY YOUNGER ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY INFANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY NEONATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY NEONATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY TODDLER, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY TODDLER, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CAREGIVER ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CAREGIVER ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 161. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 164. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 165. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 166. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 167. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 168. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 169. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 174. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 175. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 176. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 177. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 180. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 181. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 182. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 183. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 184. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 185. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. CANADA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 190. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 191. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 192. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 193. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 200. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 201. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 202. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 203. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 206. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 207. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 210. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 211. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. MEXICO RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE THERAPY, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS THERAPEUTIC DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, 2025
Samples
LOADING...
Companies Mentioned
The companies profiled in this Respiratory Syncytial Virus Therapeutic Drugs market report include:- AstraZeneca PLC
- Sanofi S.A.
- AbbVie Inc.
- GlaxoSmithKline plc
- Pfizer Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- Gilead Sciences, Inc.
- Moderna, Inc.
- Novavax, Inc.
